Financial benefits

"The peaks and troughs of financial dealings don't just apply to private businesses but they also apply to the public sector. The predictive capabilities of biomodels and the disease control methods that go along with them, don't just offer financial rewards for the National Health Service and DEFRA, but also to a variety of industries. These industries include farming, the pharmaceutical industry, tourism, catering, transport, etc."

Amongst animal populations, livestock diseases reduce productivity (in terms of meat, milk, wool, etc.) and economic farming margins can become negative due to widespread disease. For human populations, industrial output, services, travel, etc. are all affected by widespread disease. Each of the recent newsworthy epidemics (BSE, Foot-and-Mouth Disease, SARS, Avian Flu, Swine Flu, Tuberculosis, etc.) have carried significant economic consequences that have impacted, or held the potential to impact the economy.

At the local level steps can be taken to control disease and to reduce the level of pathogenic material that diseased individuals, or groups of individuals, excrete into the environment [21]. Local disease control is not only focused upon individuals but also upon their ability to spread disease onto a wider population around them. Efforts to reduce disease spread at the local level remain worthwhile.

The same principles that apply to local disease control, also apply to the control of disease spread at a regional level: the most significant difference lies in the fact that the modelling is scaled up, both geographically and temporally (or in terms of time periods). For example 'first day incidence' at the local level would become 'first fortnight incidence' at the regional level, etc.

Biomodels and any future advancements will continue to offer economic benefits to commerce.